Walker BD - Search Results

1

Immune control of HIV-1 after early treatment of acute infection.

Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD. Rosenberg ES, et al. Among authors: walker bd. Nature. 2000 Sep 28;407(6803):523-6. doi: 10.1038/35035103. Nature. 2000. PMID: 11029005 Clinical Trial.

2

Cytotoxic T lymphocytes against HIV.

Walker BD, Plata F. Walker BD, et al. AIDS. 1990 Mar;4(3):177-84. doi: 10.1097/00002030-199003000-00001. AIDS. 1990. PMID: 1693514 Review.

3

HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells.

Johnson RP, Trocha A, Yang L, Mazzara GP, Panicali DL, Buchanan TM, Walker BD. Johnson RP, et al. Among authors: walker bd. J Immunol. 1991 Sep 1;147(5):1512-21. J Immunol. 1991. PMID: 1715361

4

HIV infection is blocked in vitro by recombinant soluble CD4.

Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, et al. Fisher RA, et al. Among authors: walker bd. Nature. 1988 Jan 7;331(6151):76-8. doi: 10.1038/331076a0. Nature. 1988. PMID: 2829022

5

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.

Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang HC, Siliciano RF, Dorfman T, Walker B, Sodroski J, Reinherz EL. Hussey RE, et al. Nature. 1988 Jan 7;331(6151):78-81. doi: 10.1038/331078a0. Nature. 1988. PMID: 2829023

6

The cytotoxic T-lymphocyte response in HIV-1 infection.

Kalams SA, Walker BD. Kalams SA, et al. Among authors: walker bd. Clin Lab Med. 1994 Jun;14(2):271-99. Clin Lab Med. 1994. PMID: 7924192 Review.

7

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.

Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo HS, D'Aquila RT, Kurnick JT, Walker BD. Kalams SA, et al. Among authors: walker bd. J Exp Med. 1994 Apr 1;179(4):1261-71. doi: 10.1084/jem.179.4.1261. J Exp Med. 1994. PMID: 8145043 Free PMC article.

8

The rationale for immunotherapy in HIV-1 infection.

Walker BD. Walker BD. J Acquir Immune Defic Syndr (1988). 1994;7 Suppl 1:S6-13. J Acquir Immune Defic Syndr (1988). 1994. PMID: 8182510 Review.

9

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: walker bd. AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585. AIDS Res Hum Retroviruses. 1996. PMID: 8743084

10

Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.

Harrer T, Harrer E, Kalams SA, Barbosa P, Trocha A, Johnson RP, Elbeik T, Feinberg MB, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: walker bd. J Immunol. 1996 Apr 1;156(7):2616-23. J Immunol. 1996. PMID: 8786327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

674 results

Search Page

Filters